Encompass Health Corporation Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31)
Encompass Health Corporation (EHC) reported Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) of $32.60 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationRevenue · last filed 2020-02-27
- Encompass Health Corporation equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2019-12-31 was $5.30M, a 51.82% decline year-over-year.
- Encompass Health Corporation equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2019-09-30 was $5.20M, a 48.51% decline year-over-year.
- Encompass Health Corporation equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2019-06-30 was $10.50M, a 0.00% change year-over-year.
- Encompass Health Corporation equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for the quarter ending 2019-03-31 was $11.60M, a 5.45% increase year-over-year.
- Encompass Health Corporation equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2019 was $32.60M, a 23.47% decline from fiscal 2018.
- Encompass Health Corporation equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2018 was $42.60M, a 4.16% increase from fiscal 2017.
- Encompass Health Corporation equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2017 was $40.90M, a 8.71% decline from fiscal 2016.
- Encompass Health Corporation equity method investment, summarized financial information, revenue (deprecated 2020-01-31) for fiscal 2016 was $44.80M, a 22.74% increase from fiscal 2015.
| Period end | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 3 month as first filed | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 9 month | Equity Method Investment, Summarized Financial Information, Revenue (Deprecated 2020-01-31) 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | $5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $10.50M derived: sum of 2 quarters · filed 2020-02-27 | $21.00M derived: sum of 3 quarters · filed 2020-02-27 | $32.60M 10-K · filed 2020-02-27 | |
| 2019-09-30 | $5.20M 10-Q · filed 2019-10-31 | $15.70M derived: sum of 2 quarters · filed 2019-10-31 | $27.30M 10-Q · filed 2019-10-31 | $38.30M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2019-06-30 | $10.50M 10-Q · filed 2019-07-31 | $22.10M 10-Q · filed 2019-07-31 | $33.10M derived: sum of 3 quarters · filed 2020-02-27 | $43.20M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2019-03-31 | $11.60M 10-Q · filed 2019-05-01 | $22.60M derived: sum of 2 quarters · filed 2020-02-27 | $32.70M derived: sum of 3 quarters · filed 2020-02-27 | $43.20M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $21.10M derived: sum of 2 quarters · filed 2020-02-27 | $31.60M derived: sum of 3 quarters · filed 2020-02-27 | $42.60M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $10.10M 10-Q · filed 2019-10-31 | $20.60M derived: sum of 2 quarters · filed 2019-10-31 | $31.60M 10-Q · filed 2019-10-31 | $41.50M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $10.50M 10-Q · filed 2019-07-31 | $21.50M 10-Q · filed 2019-07-31 | $31.40M derived: sum of 3 quarters · filed 2020-02-27 | $41.30M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $11.00M 10-Q · filed 2019-05-01 | $20.90M derived: sum of 2 quarters · filed 2020-02-27 | $30.80M derived: sum of 3 quarters · filed 2020-02-27 | $41.20M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $9.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $19.80M derived: sum of 2 quarters · filed 2020-02-27 | $30.20M derived: sum of 3 quarters · filed 2020-02-27 | $40.90M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $9.90M 10-Q · filed 2018-10-31 | $20.30M derived: sum of 2 quarters · filed 2018-10-31 | $31.00M 10-Q · filed 2018-10-31 | $42.50M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | $10.40M 10-Q · filed 2018-08-02 | $21.20M 10-Q · filed 2018-08-02 | $32.60M derived: sum of 3 quarters · filed 2019-02-27 | $43.90M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | $10.80M 10-Q · filed 2018-05-02 | $22.20M derived: sum of 2 quarters · filed 2019-02-27 | $33.50M derived: sum of 3 quarters · filed 2019-02-27 | $44.40M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $11.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $22.70M derived: sum of 2 quarters · filed 2019-02-27 | $33.60M derived: sum of 3 quarters · filed 2019-02-27 | $44.80M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $11.30M 10-Q · filed 2017-10-31 | $22.20M derived: sum of 2 quarters · filed 2017-10-31 | $33.40M 10-Q · filed 2017-10-31 | $43.60M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $10.90M 10-Q · filed 2017-08-02 | $22.10M 10-Q · filed 2017-08-02 | $32.30M derived: sum of 3 quarters · filed 2018-02-28 | $41.50M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $11.20M 10-Q · filed 2017-04-28 | $21.40M derived: sum of 2 quarters · filed 2018-02-28 | $30.60M derived: sum of 3 quarters · filed 2018-02-28 | $39.50M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $10.20M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $19.40M derived: sum of 2 quarters · filed 2018-02-28 | $28.30M derived: sum of 3 quarters · filed 2018-02-28 | $36.50M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $9.20M 10-Q · filed 2016-10-28 | $18.10M derived: sum of 2 quarters · filed 2016-10-28 | $26.30M 10-Q · filed 2016-10-28 | $32.40M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2015-06-30 | $8.90M 10-Q · filed 2016-07-29 | $17.10M 10-Q · filed 2016-07-29 | $23.20M derived: sum of 3 quarters · filed 2017-09-19 | $31.00M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2015-03-31 | $8.20M 10-Q · filed 2016-04-28 | $14.30M derived: sum of 2 quarters · filed 2017-09-19 | $22.10M derived: sum of 3 quarters · filed 2017-09-19 | $37.10M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2014-12-31 | $6.10M derived: 8-K 12 month − 10-Q 9 month · filed 2017-09-19 | $13.90M derived: sum of 2 quarters · filed 2017-09-19 | $28.90M derived: sum of 3 quarters · filed 2017-09-19 | $50.20M 8-K · filed 2017-09-19 | |
| 2014-09-30 | $7.80M 10-Q · filed 2015-10-29 | $22.80M derived: sum of 2 quarters · filed 2015-10-29 | $44.10M 10-Q · filed 2015-10-29 | $63.00M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $15.00M 10-Q · filed 2015-07-30 | $36.30M 10-Q · filed 2015-07-30 | $55.20M derived: sum of 3 quarters · filed 2016-02-25 | $71.40M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | $21.30M 10-Q · filed 2015-05-01 | $40.20M derived: sum of 2 quarters · filed 2016-02-25 | $56.40M derived: sum of 3 quarters · filed 2016-02-25 | $76.10M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | $18.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $35.10M derived: sum of 2 quarters · filed 2016-02-25 | $54.80M derived: sum of 3 quarters · filed 2016-02-25 | $74.30M 10-K · filed 2016-02-25 | |
| 2013-09-30 | $16.20M 10-Q · filed 2014-10-28 | $35.90M derived: sum of 2 quarters · filed 2014-10-28 | $55.40M 10-Q · filed 2014-10-28 | $74.50M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-06-30 | $19.70M 10-Q · filed 2014-07-29 | $39.20M 10-Q · filed 2014-07-29 | $58.30M derived: sum of 3 quarters · filed 2015-03-02 | $76.90M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $19.50M 10-Q · filed 2014-04-29 | $18.90M 10-Q · filed 2013-04-26 | $38.60M derived: sum of 2 quarters · filed 2015-03-02 | $57.20M derived: sum of 3 quarters · filed 2015-03-02 | $79.80M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $19.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $37.70M derived: sum of 2 quarters · filed 2015-03-02 | $60.30M derived: sum of 3 quarters · filed 2015-03-02 | $83.30M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $18.60M 10-Q · filed 2013-10-29 | $41.20M derived: sum of 2 quarters · filed 2013-10-29 | $64.20M 10-Q · filed 2013-10-29 | $87.20M derived: sum of 4 quarters · filed 2014-02-20 | |
| 2012-06-30 | $22.60M 10-Q · filed 2013-07-30 | $45.60M 10-Q · filed 2013-07-30 | $68.60M derived: sum of 3 quarters · filed 2014-02-20 | $91.00M derived: sum of 4 quarters · filed 2014-02-20 | |
| 2012-03-31 | $23.00M 10-Q · filed 2013-04-26 | $46.00M derived: sum of 2 quarters · filed 2014-02-20 | $68.40M derived: sum of 3 quarters · filed 2014-02-20 | $89.60M derived: sum of 4 quarters · filed 2014-02-20 | |
| 2011-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $45.40M derived: sum of 2 quarters · filed 2014-02-20 | $66.60M derived: sum of 3 quarters · filed 2014-02-20 | $87.00M 10-K · filed 2014-02-20 | |
| 2011-09-30 | $22.40M 10-Q · filed 2012-10-26 | $43.60M derived: sum of 2 quarters · filed 2012-10-26 | $64.00M 10-Q · filed 2012-10-26 | $84.10M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-06-30 | $21.20M 10-Q · filed 2012-07-27 | $41.60M 10-Q · filed 2012-07-27 | $61.70M derived: sum of 3 quarters · filed 2013-02-19 | $81.10M derived: sum of 4 quarters · filed 2013-02-19 | |
| 2011-03-31 | $20.40M 10-Q · filed 2012-05-01 | $40.50M derived: sum of 2 quarters · filed 2013-02-19 | $59.90M derived: sum of 3 quarters · filed 2013-02-19 | ||
| 2010-12-31 | $20.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $39.50M derived: sum of 2 quarters · filed 2013-02-19 | $79.80M 10-K · filed 2013-02-19 | ||
| 2010-09-30 | $19.40M 10-Q · filed 2011-11-04 | $59.70M 10-Q · filed 2011-11-04 | |||
| 2009-12-31 | $73.10M 8-K · filed 2012-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |